New perspectives on the prevalence of hypertrophic cardiomyopathy

Journal of the American College of Cardiology

Volumn 65, Issue 12, 2015, Pages 1249-1254

  Semsarian, Christopher ^a,b,c   Ingles, Jodie ^a,b,c   Maron, Martin S ^d   Maron, Barry J ^e  

^a CENTENARY INSTITUTE   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

^c ROYAL PRINCE ALFRED HOSPITAL   (Australia)

^d TUFTS MEDICAL CENTER   (United States)

^e MINNEAPOLIS HEART INSTITUTE FOUNDATION   (United States)

Author keywords

genetics; hypertrophic cardiomyopathy; magnetic resonance imaging; sudden death

Indexed keywords

CARDIOVASCULAR MAGNETIC RESONANCE; COHORT ANALYSIS; ECHOCARDIOGRAPHY; GENETIC SCREENING; GENOTYPE; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; NEXT GENERATION SEQUENCING; PATIENT CARE PLANNING; PHENOTYPE; POPULATION RESEARCH; PREVALENCE; PRIORITY JOURNAL; REVIEW; CARDIOMYOPATHY, HYPERTROPHIC; DEATH, SUDDEN, CARDIAC; DOPPLER ECHOCARDIOGRAPHY; FEMALE; GENETIC PREDISPOSITION; GENETICS; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PROCEDURES; PROGNOSIS; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; SURVIVAL;

CARDIOMYOPATHY, HYPERTROPHIC; DEATH, SUDDEN, CARDIAC; ECHOCARDIOGRAPHY, DOPPLER; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MAGNETIC RESONANCE IMAGING, CINE; MALE; PHENOTYPE; PREVALENCE; PROGNOSIS; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; SURVIVAL ANALYSIS;

EID: 84925353263     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2015.01.019     Document Type: Review

References (33)

1. B.J. Maron, and M.S. Maron Hypertrophic cardiomyopathy Lancet 381 2013 242 255
2. B.J. Maron, S.R. Ommen, and C. Semsarian Hypertrophic cardiomyopathy: present and future, with translation into contemporary cardiovascular medicine J Am Coll Cardiol 64 2014 83 99
3. B.J. Maron Hypertrophic cardiomyopathy: an important global disease Am J Med 116 2004 63 65
4. B.J. Maron, J.M. Gardin, and J.M. Flack Prevalence of hypertrophic cardiomyopathy in a general population of young adults. Echocardiographic analysis of 4111 subjects in the CARDIA Study. Coronary Artery Risk Development in (Young) Adults Circulation 92 1995 785 789
5. Y. Zou, L. Song, and Z. Wang Prevalence of idiopathic hypertrophic cardiomyopathy in China: a population-based echocardiographic analysis of 8080 adults Am J Med 116 2004 14 18
6. Y. Hada, T. Sakamoto, and K. Amano Prevalence of hypertrophic cardiomyopathy in a population of adult Japanese workers as detected by echocardiographic screening Am J Cardiol 59 1987 183 184
7. H.H. Ho, K.L. Lee, and C.P. Lau Clinical characteristics of and long-term outcome in Chinese patients with hypertrophic cardiomyopathy Am J Med 116 2004 19 23
8. B.J. Maron, R. Mathenge, and S.A. Casey Clinical profile of hypertrophic cardiomyopathy identified de novo in rural communities J Am Coll Cardiol 33 1999 1590 1595
9. B.J. Maron, P. Spirito, and M.J. Roman Prevalence of hypertrophic cardiomyopathy in a population-based sample of American Indians aged 51 to 77 years (the Strong Heart Study) Am J Cardiol 93 2004 1510 1514
10. E.E. Maro, M. Janabi, and R. Kaushik Clinical and echocardiographic study of hypertrophic cardiomyopathy in Tanzania Trop Doct 36 2006 225 227
11. B.J. Maron, M.S. Maron, and C. Semsarian Genetics of hypertrophic cardiomyopathy after 20 years: clinical perspectives J Am Coll Cardiol 60 2012 705 715
12. J. Seidman, and C. Seidman The genetic basis for cardiomyopathy: from mutation identification to mechanistic paradigms Cell 104 2001 557 567
13. A.G. Bick, J. Flannick, and K. Ito Burden of rare sarcomere gene variants in the Framingham and Jackson Heart Study cohorts Am J Hum Genet 91 2012 513 519
14. D.G. MacArthur, T.A. Manolio, and D.P. Dimmock Guidelines for investigating causality of sequence variants in human disease Nature 508 2014 469 476
15. J. Ingles, and C. Semsarian The value of cardiac genetic testing Trends Cardiovasc Med 24 2014 217 224
16. B.J. Maron, and C. Semsarian Emergence of gene mutation carriers and the expanding disease spectrum of hypertrophic cardiomyopathy Eur Heart 31 2010 1551 1553
17. B.J. Maron, L. Yeates, and C. Semsarian Clinical challenges of genotype positive (+)-phenotype negative (-) family members in hypertrophic cardiomyopathy Am J Cardiol 107 2011 604 608
18. B. Gray, J. Ingles, and C. Semsarian Natural history of genotype positive-phenotype negative patients with hypertrophic cardiomyopathy Int J Cardiol 152 2011 258 259
19. G. Captur, L.R. Lopes, and T.J. Mohun Prediction of sarcomere mutations in subclinical hypertrophic cardiomyopathy Circ Cardiovasc Imaging 7 2014 863 871
20. C.Y. Ho, C. Carlsen, and J.J. Thune Echocardiographic strain imaging to assess early and late consequences of sarcomere mutations in hypertrophic cardiomyopathy Circ Cardiovasc Genet 2 2009 314 321
21. A.M. Valente, N.K. Lakdawala, and A.J. Powell Comparison of echocardiographic and cardiac magnetic resonance imaging in hypertrophic cardiomyopathy sarcomere mutation carriers without left ventricular hypertrophy Circ Cardiovasc Genet 6 2013 230 237
22. C.Y. Ho, N.K. Sweitzer, and B. McDonough Assessment of diastolic function with Doppler tissue imaging to predict genotype in preclinical hypertrophic cardiomyopathy Circulation 105 2002 2992 2997
23. B.J. Maron, M.J. Ackerman, and R.A. Nishimura Task Force 4: HCM and other cardiomyopathies, mitral valve prolapse, myocarditis, and Marfan syndrome J Am Coll Cardiol 45 2005 1340 1345
24. J. Ingles, and C. Semsarian The Australian Genetic Heart Disease Registry Int J Cardiol 168 2013 e127 e128
25. B.J. Maron, J.G. Seidman, and C.E. Seidman Proposal for contemporary screening strategies in families with hypertrophic cardiomyopathy J Am Coll Cardiol 44 2004 2125 2132
26. B.J. Maron, H. Niimura, and S.A. Casey Development of left ventricular hypertrophy in adults in hypertrophic cardiomyopathy caused by cardiac myosin-binding protein C gene mutations J Am Coll Cardiol 38 2001 315 321
27. H.G. Klues, A. Schiffers, and B.J. Maron Phenotypic spectrum and patterns of left ventricular hypertrophy in hypertrophic cardiomyopathy: morphologic observations and significance as assessed by two-dimensional echocardiography in 600 patients J Am Coll Cardiol 26 1995 1699 1708
28. M.S. Maron, B.J. Maron, and C. Harrigan Hypertrophic cardiomyopathy phenotype revisited after 50 years with cardiovascular magnetic resonance J Am Coll Cardiol 54 2009 220 228
29. M.S. Maron, J.R. Lesser, and B.J. Maron Management implications of massive left ventricular hypertrophy in hypertrophic cardiomyopathy significantly underestimated by echocardiography but identified by cardiovascular magnetic resonance Am J Cardiol 105 2010 1842 1843
30. M.S. Maron, E.J. Rowin, and D. Lin Prevalence and clinical profile of myocardial crypts in hypertrophic cardiomyopathy Circ Cardiovasc Imaging 5 2012 441 447
31. M.S. Maron Clinical utility of cardiovascular magnetic resonance in hypertrophic cardiomyopathy J Cardiovasc Magn Reson 14 2012 13
32. B.J. Maron, E.E. Peterson, and M.S. Maron Prevalence of hypertrophic cardiomyopathy in an outpatient population referred for echocardiographic study Am J Cardiol 73 1994 577 580
33. E.J. Rowin, M.S. Maron, and S.A. Casey Evidence for reduced mortality in an adult cohort with hypertrophic cardiomyopathy (abstr) Circulation 128 2013 A13294